ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

BSGM BioSig Technologies Inc

1.32
0.02 (1.54%)
27 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
BioSig Technologies Inc BSGM NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.02 1.54% 1.32 09:39:01
Open Price Low Price High Price Close Price Previous Close
1.31 1.2701 1.39 1.37 1.30
more quote information »

Recent News

Date Time Source Heading
05/4/202402:35GLOBEBioSig Engages Consulting Firm for Business Model Strategies
12/3/202400:00EDGAR2Form 8-K - Current report
05/3/202412:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202401:00EDGAR2Form 8-K - Current report
21/2/202402:00GLOBEBioSig Announces Reduction of its Workforce
15/2/202407:31EDGAR2Form SC 13G - Statement of acquisition of beneficial..
07/2/202400:35EDGAR2Form 8-K - Current report
07/2/202400:30GLOBEBioSig’s PURE EP™ Platform with New Near Field Tracking..
03/2/202409:18EDGAR2Form 8-K/A - Current report: [Amend]
02/2/202409:25EDGAR2Form 8-K - Current report
01/2/202408:05EDGAR2Form 8-K - Current report
01/2/202403:15GLOBEBioSig Announces Reverse Stock Split
31/1/202400:52EDGAR2Form 8-K - Current report
31/1/202400:30GLOBEBioSig Announces Cost Reductions to Improve its Financial..
17/1/202408:15EDGAR2Form D - Notice of Exempt Offering of Securities
13/1/202409:28EDGAR2Form 8-K - Current report
09/1/202403:00EDGAR2Form 8-K - Current report
06/1/202408:16EDGAR2Form S-3/A - Registration statement under Securities Act of..
05/1/202408:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/12/202305:37EDGAR2Form DEL AM - Delaying amendment
29/12/202308:30EDGAR2Form 8-K - Current report
29/12/202308:05EDGAR2Form S-3 - Registration statement under Securities Act of..
23/12/202308:30EDGAR2Form 8-K - Current report
19/12/202308:36EDGAR2Form 8-K - Current report
07/12/202309:07EDGAR2Form 8-K - Current report
07/12/202306:20GLOBEBioSig Issues Letter to Shareholders Detailing Technology..
06/12/202309:29EDGAR2Form 8-K - Current report
05/12/202312:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/12/202311:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/12/202301:13EDGAR2Form DEF 14A - Other definitive proxy statements
22/11/202309:32EDGAR2Form PRE 14A - Other preliminary proxy statements
15/11/202309:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/11/202309:02EDGAR2Form 8-K - Current report
14/11/202308:30GLOBEBioSig Announces $2.5 Million Registered Direct Offering..
14/11/202300:35EDGAR2Form 8-K - Current report
10/11/202300:00GLOBEBioSig Announces $2.5 Million Registered Direct Offering..
09/11/202308:05EDGAR2Form 8-K - Current report
08/11/202300:01EDGAR2Form 8-K - Current report
08/11/202300:00GLOBEBioSig Appoints Global MedTech Leader Fred Hrkac as New..
04/11/202307:32EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
04/11/202307:30EDGAR2Form DEF 14A - Other definitive proxy statements
02/11/202323:00EDGAR2Form 8-K - Current report
02/11/202323:00GLOBEBioSig’s New PURE EP™ Subscription Model Adopted by Mayo..
02/11/202322:17EDGAR2Form 8-K - Current report
01/11/202323:35EDGAR2Form 8-K - Current report
01/11/202323:30GLOBEBioSig Adds Five New Patent Awards to 100+ Total Patent..
25/10/202307:30EDGAR2Form PRE 14A - Other preliminary proxy statements
17/10/202308:00EDGAR2Form 8-K - Current report
28/9/202307:01EDGAR2Form 8-K - Current report
16/9/202306:54EDGAR2Form 8-K - Current report

Your Recent History

Delayed Upgrade Clock